Connect with us

Business

US Approves GSK Lung Disease Drug, Fueling Sanofi Rivalry
Advertisement

Business

The inside story of Scale cofounder Alexandr Wang's rise and the $14 billion Meta deal

Business

U.S. strikes in Iran spark airline cancellations and travel turmoil

Business

U.S. joins Iran-Israel war stoking worries about oil volatility

Business

Kinterra Capital Submits Proposal to Acquire 100% of New World Resources

Business

Israel weighs next phase of Iran campaign after US strikes

Business

China’s Rains Arrive at Critical Moment for Coal and Dam Sectors

Business

AGSI's Silliman Outlook on MidEast Conflict

Business

U.S. attacks on Iran resemble a 'TikTok-style war'

Business

UN Security Council meets on Iran as Russia, China push for a ceasefire

Business

Have Trump's Iran strikes bolstered or eroded his credibility?

Business

Faraday Future Founder and Co-CEO, YT Jia, Shares Weekly Investor Update - FX Pushes Scenario-as-Store Frontier, Signs 500-Unit Deposit Agreement with Leading MCN Telling Inc., FX Super One B2B

Business

Iran foreign minister to hold talks with Putin in Moscow

Business

Tesla Starts Long-Awaited Robotaxi Service With Low-Key Rollout

Business

World Braces for Iran’s Response After US Strikes

Business

US Approves GSK Lung Disease Drug, Fueling Sanofi Rivalry

Published

4 weeks ago

on

US Approves GSK Lung Disease Drug, Fueling Sanofi Rivalry




GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.



Source link

Related Topics:
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2025, WordupNews powered by WordPress.